These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 670701)

  • 21. Germinal centre proliferation in response to mitogenic lymphokines.
    Kelly RH; Wolstencroft RA
    Clin Exp Immunol; 1974 Nov; 18(3):321-36. PubMed ID: 4469486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of macrophage Fc-dependent phagocytosis by resident thymocytes: effect of a unique heat-stable lymphokine.
    Coleman DL; Root RK; Ryan JL
    J Immunol; 1983 May; 130(5):2195-9. PubMed ID: 6339624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mediators in cellular immunity (author's transl)].
    Sawada J; Osawa T
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):860-75. PubMed ID: 4612616
    [No Abstract]   [Full Text] [Related]  

  • 24. Antigen-enhanced glucosamine incorporation by peritoneal macrophages in cell-mediated hypersensitivity. I. Studies on biology and mechanism.
    Hammond ME; Selvaggio SS; Dvorak HF
    J Immunol; 1975 Oct; 115(4):914-21. PubMed ID: 1100724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of macrophage procoagulant by products of activated lymphocytes.
    Geczy CL
    Haemostasis; 1984; 14(5):400-11. PubMed ID: 6398241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigen-induced proliferation of guinea pig lymphocytes in vitro: obligatory role of macrophages in the recognition of antigen by immune T-lymphocytes.
    Waldron JA; Horn RG; Rosenthal AS
    J Immunol; 1973 Jul; 111(1):58-64. PubMed ID: 4541326
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.
    Thomson AW; Moon DK; Geczy CL; Nelson DS
    Immunology; 1983 Feb; 48(2):291-9. PubMed ID: 6337088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocyte chemotaxis in inflammation. IX. Further characterization of lymphocyte chemotactic lymphokines produced by purified protein derivative-stimulation in vitro and in vivo.
    Harita S; Shimokawa Y; Mibu Y; Ishida M; Hayashi H
    Immunology; 1984 Feb; 51(2):295-303. PubMed ID: 6420334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible involvement of macrophage-mediated hepatocytotoxicity in chronic active hepatitis: the induction of liver cell injury by culture supernatant of MAF-activated macrophages.
    Mizoguchi Y; Shiba T; Ohnishi F; Monna T; Yamamoto S; Nakai K; Otani S; Morisawa S
    Hepatogastroenterology; 1981 Oct; 28(5):254-7. PubMed ID: 7047339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of action of 'lymphocyte activating factor' (LAF) I. Association of lymphocyte activating factor action with early DNA synthesis in PHA-stimulated lymphocytes.
    Kiertdzenbaum F; Waksman BH
    Immunology; 1977 Nov; 33(5):663-9. PubMed ID: 590994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental autoimmune uveitis: cellular immune responsiveness.
    Nussenblatt RB; Gery I; Wacker WB
    Invest Ophthalmol Vis Sci; 1980 Jun; 19(6):686-90. PubMed ID: 6966620
    [No Abstract]   [Full Text] [Related]  

  • 32. Liposomes as lymphokine activity indicators in the electrophoretic mobility test.
    Schütt W; Jenssen HL; Werner H; Köhler H
    Acta Biol Med Ger; 1977; 36(2):281-4. PubMed ID: 333836
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemical characterization of radiolabeled lymphocyte activation products of guinea pig associated with macrophage migration inhibitory activity (MIF).
    Klinkert W; Sorg C
    Adv Exp Med Biol; 1979; 114():469-74. PubMed ID: 380298
    [No Abstract]   [Full Text] [Related]  

  • 34. Release of a lymphokine-like plasminogen activator by stimulated B lymphocytes.
    Toullet F; Maillard JL; Favreau C
    J Immunol; 1983 Jan; 130(1):254-60. PubMed ID: 6600183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applications of the macrophage electrophoretic mobility test (M.E.M.).
    Shenton BR
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):557-64. PubMed ID: 629849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of interferon and lymphokines on lymphocytes.
    Gifford GE; Tobey M
    Tex Rep Biol Med; 1977; 35():375-80. PubMed ID: 358461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biologic effects of allogeneic effect factor on T lymphocytes. I. The mitogenic activity and the autonomous induction of cytotoxic T lymphocytes by AEF.
    Altman A; Cardenas JM; Bechtold TE; Katz DH
    J Immunol; 1980 Jan; 124(1):105-13. PubMed ID: 6444223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The induction and regulation of guinea pig B-lymphocyte proliferation in vitro.
    Lipsky PE; Rosenthal AS
    J Immunol; 1976 Nov; 117(5 Pt 1):1594-1602. PubMed ID: 1087318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandins and lymphokines in arthritis.
    Morley J
    Prostaglandins; 1974 Nov; 8(4):315-26. PubMed ID: 4450028
    [No Abstract]   [Full Text] [Related]  

  • 40. Dexamethasone suppresses concanavalin A-induced production of chemotactic lymphokines by releasing a soluble factor from splenic T lymphocytes.
    Hirashima M; Sakata K; Tashiro K; Yoshimura T; Hayashi H
    Immunology; 1985 Mar; 54(3):533-40. PubMed ID: 3871733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.